Fingerprint
Dive into the research topics of 'Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: Final results from the PILLAR-2 randomized phase III trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: Final results from the PILLAR-2 randomized phase III trial
T. E. Witzig, K. Tobinai, L. Rigacci, T. Ikeda, A. Vanazzi, M. Hino, Y. Shi, J. Mayer, L. J. Costa, C. D. Bermudez Silva, J. Zhu, D. Belada, K. Bouabdallah, J. G. Kattan, J. Kuruvilla, W. S. Kim, J. F. Larouche, M. Ogura, M. Ozcan, L. Fayad
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations